Stock GLAND GLAND PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Gland Pharma Limited

Equities

GLAND

INE068V01023

Market Closed - NSE India S.E.
Other stock markets
 07:43:52 2024-05-13 am EDT 		5-day change 1st Jan Change
1,764 INR +3.18% Intraday chart for Gland Pharma Limited +4.62% -8.32%
May. 07 Gland Pharma Gets US FDA's Approval for Generic ALS Drug MT
May. 07 Gland Pharma Gets US FDA's Approval for Generic Stem Cell Mobilizer Injection MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
KKR to buy India's Healthium Medtech at $839 million valuation, sources say
RE
Gland Pharma Gets US FDA's Final Approval for Generic Drug for Luteinizing Hormone Surges
MT
Gland Pharma Receives Approval for Cetrorelix Acetate for Injection
CI
Nicomac Machinery and RP Advisory Services Reportedly Likely to Sell 4.4% Stake in Gland Pharma via Block Deals
CI
Gland Pharma Gets US FDA Approval for Eribulin Mesylate Injection
MT
Gland Pharma Limited Receives Approval from the United States Food and Drug Administration for Eribulin Mesylate Injection 0.5 Mg/ML Single Dose Vial
CI
Gland Pharma's Consolidated Profit Drops in Fiscal Q3
MT
Gland Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Gland Pharma Gets Establishment Inspection Report from US FDA for Pashamylaram Unit
MT
Gland Pharma Limited Receives Tentative Approval for Angiotensin II Injection
CI
Abbott India's Q2 profit climbs on strong sales
RE
Gland Pharma Gets US FDA's EIR Report Closing Inspection of Visakhapatnam, India Unit
MT
Indian shares set to open marginally higher
RE
India's Gland Pharma misses Q2 profit view on higher expenses
RE
Gland Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
Gland Pharma Gets EIR from US FDA After Inspection of Pashamylaram Facility in India
MT
Gland Pharma's Pashamylaran Plant in India Gets Two Observations from US FDA
MT
Gland Pharma Receives US FDA's Establishment Inspection Report for Hyderabad, India Unit
MT
Gland Pharma' Consolidated Profit Drops in Fiscal Q1; Shares Soar 20%
MT
India's Gland Pharma posts 41% jump in quarterly revenue on Cenexi acquisition
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GLAND Stock
  4. News Gland Pharma Limited
  5. Highlights
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW